Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Autolus Therapeutics (AUTL) Equity Ratio (2017 - 2025)

Historic Equity Ratio for Autolus Therapeutics (AUTL) over the last 9 years, with Q3 2025 value amounting to 0.4.

  • Autolus Therapeutics' Equity Ratio fell 3042.73% to 0.4 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.4, marking a year-over-year decrease of 3042.73%. This contributed to the annual value of 0.55 for FY2024, which is 8384.33% up from last year.
  • Autolus Therapeutics' Equity Ratio amounted to 0.4 in Q3 2025, which was down 3042.73% from 0.48 recorded in Q2 2025.
  • Over the past 5 years, Autolus Therapeutics' Equity Ratio peaked at 0.77 during Q4 2021, and registered a low of 0.3 during Q4 2023.
  • Over the past 5 years, Autolus Therapeutics' median Equity Ratio value was 0.58 (recorded in 2023), while the average stood at 0.56.
  • In the last 5 years, Autolus Therapeutics' Equity Ratio crashed by 5125.36% in 2023 and then surged by 8384.33% in 2024.
  • Quarter analysis of 5 years shows Autolus Therapeutics' Equity Ratio stood at 0.77 in 2021, then decreased by 21.15% to 0.61 in 2022, then tumbled by 51.25% to 0.3 in 2023, then soared by 83.84% to 0.55 in 2024, then decreased by 26.55% to 0.4 in 2025.
  • Its last three reported values are 0.4 in Q3 2025, 0.48 for Q2 2025, and 0.5 during Q1 2025.